deals

MUMBAI: Biocon has entered into a licensing agreement with a global biopharmaceutical company to develop and market a bio-similar version of granulocyte-colony stimulating factor in North America and the European Union. Under the agreement, Biocon will receive an upfront licensing fee, and...

‘WE CAN FIND DEALS EVEN IN THIS MARKET’ The Economic Times Apax partners, the global private equity group, has joined the growing list of PE funds looking to benefit from the India story. Dr Martin Halusa, CEO Apax Partners Worldwide LLP is hopeful of finding good deals here, too. Excerpts...